Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yi,Li

第一单位： State Key Laboratory of Frigid Zone Cardiovascular Disease, General Hospital of Northern Theater Command, Shenyang, China.

作者： Yi,Li ^[1] ; Jing,Li ^[1] ; Bin,Wang ^[1] ; Quanmin,Jing ^[1] ; Yujie,Zeng ^[2] ; Aijie,Hou ^[3] ; Zhifang,Wang ^[4] ; Aijun,Liu ^[5] ; Jinliang,Zhang ^[6] ; Yaojun,Zhang ^[7] ; Ping,Zhang ^[8] ; Daming,Jiang ^[9] ; Bin,Liu ^[10] ; Jiamao,Fan ^[11] ; Jun,Zhang ^[12] ; Li,Li ^[13] ; Guohai,Su ^[14] ; Ming,Yang ^[15] ; Weihong,Jiang ^[16] ; Peng,Qu ^[17] ; Hesong,Zeng ^[18] ; Lu,Li ^[19] ; Miaohan,Qiu ^[1] ; Leisheng,Ru ^[20] ; Shaoliang,Chen ^[21] ; Yujie,Zhou ^[2] ; Shubin,Qiao ^[22] ; Gregg W,Stone ^[23] ; Dominick J,Angiolillo ^[24] ; Yaling,Han ^[1] ; OPT-BIRISK Investigators

作者单位： State Key Laboratory of Frigid Zone Cardiovascular Disease, General Hospital of Northern Theater Command, Shenyang, China. ^[1] Beijing Anzhen Hospital, Capital Medical University, Beijing, China. ^[2] The People's Hospital of Liaoning Province, Shenyang, China. ^[3] Xinxiang Central Hospital, Xinxiang, China. ^[4] Benxi Central Hospital, Benxi, China. ^[5] Meihekou Central Hospital, Meiheko, China. ^[6] Xuzhou Third People's Hospital, Xuzhou, China. ^[7] Beijing Tsinghua Changgung Hospital, Beijing, China. ^[8] Dandong Central Hospital, Dandong, China. ^[9] The Second Hospital of Jilin University, Changchun, China. ^[10] Linfen Central Hospital, Linfen, China. ^[11] Cangzhou Central Hospital, Cangzhou, China. ^[12] Guangzhou Red Cross Hospital, Guangzhou, China. ^[13] Central Hospital Affiliated to Shandong First Medical University, Ji'nan, China. ^[14] Yingkou Central Hospital, Yingkou, China. ^[15] The Third Xiangya Hospital of Central South University, Changsha, China. ^[16] The Second Hospital of Dalian Medical University, Dalian, China. ^[17] Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. ^[18] The Second Affiliated Hospital of Shenyang Medical College, Shenyang, China. ^[19] Bethune International Peace Hospital, Shijiazhuang, China. ^[20] Nanjing First Hospital, Nanjing, China. ^[21] Fuwai Hospital Chinese Academy of Medical Sciences, Beijing, China. ^[22] The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. ^[23] University of Florida College of Medicine, Jacksonville. ^[24]

主题词人类(Humans);急性冠状动脉综合征(Acute Coronary Syndrome);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);双盲法(Double-Blind Method);出血(Hemorrhage);血小板聚集抑制剂(Platelet Aggregation Inhibitors);老年人(Aged);阿司匹林(Aspirin);药物洗脱支架(Drug-Eluting Stents);嘌呤能P2Y受体拮抗剂(Purinergic P2Y Receptor Antagonists)

DOI 10.1001/jamacardio.2024.0534

PMID 38630489

发布时间 2024-07-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA cardiology

2024年9卷6期

523-531页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial.

JAMA cardiology

相似文献

JAMA cardiology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial.

JAMA cardiology

相似文献

JAMA cardiology

相关期刊

检索历史清除